Fact CheckerSign in

NCT07333807Completed

Efficacy of the Pelvic Clock® Device for Functional Recovery After Robotic-Assisted Radical Prostatectomy

Efficacy of the Pelvic Clock® Device on Functional Recovery After Robotic-Assisted Radical Prostatectomy: A Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 12 Jan 2026

Brief summary (registry, in English)

This randomized controlled trial evaluates the efficacy of the Pelvic Clock® device, a proprioceptive neuromuscular facilitation tool, in accelerating functional recovery following Robotic-Assisted Radical Prostatectomy (RARP). The study compares the device intervention against standard Pelvic Floor Muscle Training (PFMT) instructions. The primary goal is to assess the "Trifecta" achievement rate (cancer control, urinary continence, and potency) at 6 months post-surgery.

Status (registry)
Completed
Study type
Interventional
Enrollment
60 (actual)
First submitted
30 Dec 2025
Start date
Oct 2024
Primary completion date
Aug 2025
Lead sponsor
Tri-Service General Hospital (TSGH)
NCT number
NCT07333807

What you commit to

  • Study type: Interventional
  • Participants enrolled: 60
  • From Oct 2024 to the primary completion date, Aug 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Adjuvant radiotherapy or androgen deprivation therapy.
  • Prior pelvic surgery or radiation.

Other illness

  • History of neurological disorders affecting pelvic floor function (e.g., -Parkinson's disease, multiple sclerosis, CVA).
  • Cognitive impairment or physical inability to perform prescribed exercises .

Other

  • Salvage prostatectomy.
  • Advanced tumor stage (cT4 or N+).

Who the study is looking for

  • Diagnosed with localized prostate cancer.
  • Scheduled for Robotic-Assisted Radical Prostatectomy (RARP).
  • Age between 55 and 80 years.

Age in the registry: 55 years to 80 years · Sex: Male · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Tri-Service General Hospital
Coordinator of this site? Confirm its status
TaipeiTaiwanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.